Rapid bupropion-induced hepatotoxicity: a case report and review of the literature
Abstract Background Bupropion is an antidepressant that is also used as a non-nicotine method to aid in smoking cessation. Bupropion-induced hepatotoxicity is quoted to affect between 0.1% and 1% of treated patients with either a hepatocellular and/or cholestatic pattern of damage. The mechanism of...
Main Authors: | Sulakchanan Anandabaskaran, Vincent Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-018-1563-9 |
Similar Items
-
Bupropion-induced leukopenia: A case report (eng)
by: Gamze Gürcan, et al.
Published: (2021-09-01) -
Development of Hyperprolactinemia Induced by the Addition of Bupropion to Venlafaxine XR Treatment
by: Alperen KILIÇ, et al.
Published: (2018-04-01) -
Seizures After Overdoses of Bupropion Intake
by: Hasan Kara, et al.
Published: (2013-06-01) -
Methaemoglobinemia Induced by Poppers and Bupropion Intoxication in the Emergency Department
by: Frederico Batista, et al.
Published: (2019-03-01) -
Bupropion v. Methylphenidate in ADHD
by: J Gordon Millichap
Published: (1995-06-01)